Axogen, Inc. (AXGN) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Axogen’s revenue went from $41M in fiscal 2016 to $225M in fiscal 2025, growth of about 20.8% a year.
Net income in fiscal 2025 was -$16M, a net margin of -7.0%; the best year in this period was 2024 with -$10M.
Over the twelve months to September 30, 2026, revenue was $267M and net income -$32M.
Free cash flow was -$3M in fiscal 2025 and positive in 1 of the 10 years shown.
The diluted share count rose 50% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $267M | $225M | $187M | $159M | $139M | $127M | $112M | $107M | $84M | $60M | $41M |
| Gross profit | $198M | $167M | $142M | $122M | $109M | $104M | $91M | $89M | $71M | $51M | $35M |
| Operating income | -$14M | -$8M | -$3M | -$21M | -$30M | -$25M | -$23M | -$31M | -$20M | -$8M | -$8M |
| Net income | -$32M | -$16M | -$10M | -$22M | -$29M | -$27M | -$24M | -$29M | -$22M | -$10M | -$14M |
| EPS (diluted) | $-0.63 | $-0.34 | $-0.23 | $-0.51 | $-0.69 | $-0.65 | $-0.60 | $-0.74 | $-0.60 | $-0.00 | $-0.00 |
| R&D | $37M | $33M | $28M | $27M | $26M | $24M | $18M | $18M | $12M | $7M | $4M |
| Revenue growth | — | +20.2% | +17.8% | +14.7% | +8.8% | +13.4% | +5.2% | +27.1% | +38.9% | +47.0% | +50.4% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $28M | $812000 | $5M | -$6M | -$16M | -$13M | -$10M | -$20M | -$18M | -$9M | -$11M |
| Capital spending | -$6M | -$4M | -$3M | -$14M | -$20M | -$28M | -$22M | -$5M | -$6M | -$1M | -$931000 |
| Free cash flow | $22M | -$3M | $1M | -$20M | -$36M | -$41M | -$32M | -$25M | -$24M | -$10M | -$12M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $41M | $30M | $16M | $14M | $16M | $11M | $8M | $10M | $8M | $4M | $1M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $42M | $33M | $31M | $49M | $84M | $104M | $97M | $117M | $37M | $30M |
| Debt | — | $68M | $69M | $69M | $67M | $67M | $54M | $5M | $63000 | $21M | $20M |
| Equity | — | $129M | $104M | $96M | $101M | $113M | $123M | $132M | $147M | $25M | $15M |
| Total assets | — | $222M | $204M | $197M | $195M | $208M | $201M | $155M | $160M | $59M | $46M |
| Shares (diluted) | 62M | 46M | 44M | 43M | 42M | 41M | 40M | 39M | 37M | 33M | 31M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 74.2% | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% | 80.8% | 83.7% | 84.6% | 84.6% | 84.3% |
| Operating margin | -5.2% | -3.5% | -1.8% | -13.5% | -21.4% | -20.0% | -20.6% | -29.4% | -24.4% | -13.2% | -19.8% |
| Net margin | -12.0% | -7.0% | -5.3% | -13.7% | -20.9% | -21.2% | -21.2% | -27.3% | -26.7% | -17.3% | -35.1% |
| FCF margin | 8.3% | -1.3% | 0.8% | -12.3% | -26.1% | -32.4% | -28.1% | -23.0% | -28.8% | -17.1% | -29.6% |
| ROIC | — | -3.2% | -1.5% | -10.3% | -13.9% | -11.2% | -10.3% | -18.1% | -11.0% | -13.7% | -18.2% |
| ROE | — | -12.2% | -9.6% | -22.7% | -28.7% | -24.0% | -19.3% | -22.1% | -15.2% | -41.5% | -96.6% |
Frequently asked questions
What is Axogen’s annual revenue?
$225M in fiscal 2025 and $267M over the twelve months to September 30, 2026.
How much profit does Axogen make?
Net income was -$16M in fiscal 2025 (net margin -7.0%).
Is Axogen’s revenue growing?
Yes: revenue rose 20.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.